Introduction: Motor dysfunction severely reduces quality of life and is frequently linked to neurodegenerative disorders. By inhibiting succinate dehydrogenase, 3-nitropropionic acid (3-NP), a toxin, targets mitochondria and results in neurodegeneration. Neurons perish and lose energy as a result. Numerous models of neurodegenerative diseases with motor impairment have made use of this neurotoxic impact. Because of its phytoconstituents, the medicinal plant Rauwolfia vomitoria (RV) has neuroprotective qualities. The precise effects of RV on oxidative stress brought on by 3-NP and the deterioration of motor coordination, however, are still poorly understood. The objective of this research is to assess RV’s neuroprotective benefits against oxidative stress and motor impairment brought on by 3-NP in mice.
Materials & Methods: At 10 weeks of age, thirty Swiss male mice weighing between 19 and 35 g were split into three groups at random (n=10) and given the following treatments: Group II received 3-NP 15 mg/kg intraperitoneally (i.p.) for 5 days, group III received 3-NP 15 mg/kg (i.p.) and RV 20 mg/kg (p.o.), and group I received 2 mL of distilled water orally (p.o.) as the control. The beam walk test was used to assess motor coordination on the final day of the 21-day treatment. Following the neurobehavioral experiments, the animals were put to sleep, and blood was drawn by cardiac puncture. The levels of catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured in the samples. 3-NP significantly reduced motor coordination, as demonstrated by the increase in foot slips, decreases in reversals, and line crossings during the beam walk test.
Results: Concurrently, 3-NP generated oxidative stress, as demonstrated by increased levels of MDA and a decrease in levels of CAT, SOD, and GSH. Upon administration of RV, a considerable amelioration of the motor impairments and decreased oxidative stress generated by 3-NP occurred, which was indicated by an increase in the levels of CAT, SOD, and GPx and a reduction in MDA.
Conclusion: In a 3-NP-induced model of motor dysfunction, the study’s results demonstrated RV’s neuroprotective capability and antioxidant qualities. They also point to RV as a possible treatment for movement disorders. |
References
- Baladron J, Vitay J, Fietzek T, Hamker FH. The contribution of the basal ganglia and cerebellum to motor learning: A neuro-computational approach. PLoS Comput Biol. 2023; 19(4):e1011024. [DOI:10.1371/journal.pcbi.1011024] [PMID]
- Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, et al. Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation. Parkinsons Dis. 2016; 2016:9832839.[DOI:10.1155/2016/9832839] [PMID]
- Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al. Mitochondrial dysfunction: Mechanisms and advances in therapy. Signal Transduct Target Ther. 2024; 9(1):124. [DOI:10.1038/s41392-024-01839-8] [PMID]
- Túnez I, Tasset I, La Cruz VP, Santamaría A. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington’s disease: Past, present and future. Molecules. 2010; 15(2):878-916. [DOI:10.3390/molecules15020878] [PMID]
- Wu CL, Hwang CS, Chen SD, Yin JH, Yang DI. Neuroprotective mechanisms of brain-derived neurotrophic factor against 3-nitropropionic acid toxicity: Therapeutic implications for Huntington’s disease. Ann N Y Acad Sci. 2010; 1201:8-12.[DOI:10.1111/j.1749-6632.2010.05628.x] [PMID]
- Gil-Mohapel J, Brocardo PS, Christie BR. The role of oxidative stress in Huntington's disease: Are antioxidants good therapeutic candidates? Curr Drug Targets. 2014; 15(4):454-68. [DOI:10.2174/1389450115666140115113734] [PMID]
- Higdon A, Diers AR, Oh JY, Landar A, Darley-Usmar VM. Cell signalling by reactive lipid species: New concepts and molecular mechanisms. Biochem J. 2012; 442(3):453-64. [DOI:10.1042/BJ20111752] [PMID]
- Kumar A, Ratan RR. Oxidative stress and huntington’s disease: The good, the bad, and the ugly. J Huntingtons Dis. 2016; 5(3):217-37. [DOI:10.3233/JHD-160205] [PMID]
- Mock JT, Chaudhari K, Sidhu A, Sumien N. The influence of vitamins E and C and exercise on brain aging. Exp Gerontol. 2017; 94:69-72. [DOI:10.1016/j.exger.2016.12.008] [PMID]
- Amoateng P, Quansah E, Karikari TK, Asase A, Osei-Safo D, Kukuia KKE, et al. Medicinal plants used in the treatment of mental and neurological disorders in Ghana. Evid Based Complement Alternat Med. 2018; 2018:8590381. [DOI:10.1155/2018/8590381] [PMID]
- Okolie NP, Israel EE, Falodun A. In-vitro evaluation of antioxidant potential of Rauwolfia vomitoria root extract and its inhibitory effect on lipid peroxidation as indication of aphrodisiac properties. Pharm Chem J. 2011; 45(8):476-80. [DOI:10.1007/s11094-011-0660-5]
- Fapojuwomi OA, Asinwa IO. Assessment of medicinal values of Rauvolfia vomitoria (Afzel) in Ibadan Municipality. Greener J Med Sci. 2013; 3(2):37-41. [DOI:10.15580/gjms.2013.2.012013398]
- Bisong SA, Brown RE, Osim EE. Comparative extrapyramidal effects of Rauvolfia vomitoria, chlorpromazine and reserpine in mice. J Nat Med. 2012; 67(1):107-12. [DOI:10.1007/s11418-012-0657-8] [PMID]
- Afolayan FI, Sulaiman KA, Okunade WT, Garrido G. Ethnobotanical survey of plants used in cancer therapy in Iwo and Ibadan, South-Western of Nigeria. J Pharm Pharmacogn Res. 2020; 8(5):346-67. [Link]
- Kumar S, Kumari D, Singh B. Genus Rauvolfia: A review of its ethnopharmacology, phytochemistry, quality control/quality assurance, pharmacological activities and clinical evidence. J Ethnopharmacol. 2022; 295:115327. [DOI:10.1016/j.jep.2022.115327] [PMID]
- Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: A user’s guide. Nat Rev Neurosci. 2009; 10(7):519-29. [DOI:10.1038/nrn2652] [PMID]
- Carter RJ, Morton J, Dunnett SB. Motor coordination and balance in rodents. Curr Protoc Neurosci. 2001; Chapter 8:Unit 8.12. [DOI:10.1002/0471142301.ns0812s15] [PMID]
- Luchese C, Pinton S, Nogueira CW. Brain and lungs of rats are differently affected by cigarette smoke exposure: antioxidant effect of an organoselenium compound. Pharmacol Res. 2009; 59(3):194-201. [DOI:10.1016/j.phrs.2008.11.006] [PMID]
- Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247(10):3170-5. [DOI:10.1016/S0021-9258(19)45228-9] [PMID]
- Choudhary M, Jetley UK, Khan MA, Zutshi S, Fatma T. Effect of heavy metal stress on proline, malondialdehyde, and superoxide dismutase activity in the cyanobacterium Spirulina platensis-S5. Ecotoxicol Environ Saf. 2007; 66(2):204-9.[DOI:10.1016/j.ecoenv.2006.02.002] [PMID]
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-8. [DOI:10.1016/0003-2697(79)90738-3] [PMID]
- Kadir A, Singh J, Rahi V, Kumar P. Berberine ameliorates haloperidol and 3-Nitropropionic acid-induced neurotoxicity in rats. Neurochem Res. 2022; 47(11):3285-97. [DOI:10.1007/s11064-022-03677-y] [PMID]
- Kang B, Wang X, Xu Q, Wu Y, Si X, Jiang D. Effect of 3-nitropropionic acid inducing oxidative stress and apoptosis of granulosa cells in geese. Biosci Rep. 2018; 38(5):BSR20180274. [DOI:10.1042/bsr20180274] [PMID]
- Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr. 2003; 22(1):18-35. [DOI:10.1080/07315724.2003.10719272] [PMID]
- Rahmani B, Zendehdel M, Babapour V, Sadeghinezhad J, Alirezaei M. Evaluation of betaine neuroprotective effects on 6-hydroxydopamine-induced hemi-Parkinsonism in male Wistar rats. Iran J Vet Med. 2019; 13(3):290-302. [DOI:10.22059/ijvm.2019.275444.1004968]
|
